Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

May 5, 2003

Primary Completion Date

January 29, 2004

Study Completion Date

January 29, 2004

Conditions
DiabetesDiabetes Mellitus, Type 1
Interventions
DRUG

insulin aspart

Trial Locations (34)

1096

Novo Nordisk Investigational Site, Budapest

4400

Novo Nordisk Investigational Site, Nyíregyháza

15018

Novo Nordisk Investigational Site, Prague

16043

Novo Nordisk Investigational Site, Chiavari

43100

Novo Nordisk Investigational Site, Parma

45770

Novo Nordisk Investigational Site, Marl

47900

Novo Nordisk Investigational Site, Rimini

53474

Novo Nordisk Investigational Site, Bad Neuenahr-Ahrweiler

55100

Novo Nordisk Investigational Site, Lucca

55469

Novo Nordisk Investigational Site, Simmern

55545

Novo Nordisk Investigational Site, Bad Kreuznach

60325

Novo Nordisk Investigational Site, Frankfurt

61440

Novo Nordisk Investigational Site, Oberursel

65582

Novo Nordisk Investigational Site, Diez

66121

Novo Nordisk Investigational Site, Saarbrücken

66299

Novo Nordisk Investigational Site, Friedrichsthal

66386

Novo Nordisk Investigational Site, Saint Ingbert

66780

Novo Nordisk Investigational Site, Rehlingen-Siersburg

67346

Novo Nordisk Investigational Site, Speyer

76133

Novo Nordisk Investigational Site, Karlsruhe

97072

Novo Nordisk Investigational Site, Würzburg

97828

Novo Nordisk Investigational Site, Marktheidenfeld

500 36

Novo Nordisk Investigational Site, Hradec Králové

09124

Novo Nordisk Investigational Site, Cagliari

06012

Novo Nordisk Investigational Site, Città di Castello

05018

Novo Nordisk Investigational Site, Orvieto

06126

Novo Nordisk Investigational Site, Perugia

00128

Novo Nordisk Investigational Site, Roma

00133

Novo Nordisk Investigational Site, Roma

41-902

Novo Nordisk Investigational Site, Bytom

09-400

Novo Nordisk Investigational Site, Mazowieckie

26-600

Novo Nordisk Investigational Site, Radom

03-242

Novo Nordisk Investigational Site, Warsaw

50-306

Novo Nordisk Investigational Site, Wroclaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY